Cardio-Renal Effects of the A1 Adenosine Receptor Antagonist SLV320 in Patients With Heart Failure

200932 citationsJournal Articlebronze Open Access

Authors

Veselin Mitrović · Stavanger University Hospital

Petar Seferović · Stavanger University Hospital

Slobodan Dodić · Institut za kardiovaskularne bolesti Dedinje

Mirjana Krotin · Solvay (Netherlands)

Aleksandar Nešković · University Hospital Medical Center Bezanijska kosa

Kenneth Dickstein · Stavanger University Hospital

Hanka de Voogd

Abstract

SLV320 infusion shows no immediate effects on cardiac hemodynamics. SLV320 might improve glomerular filtration rate while simultaneously promoting natriuresis and diuresis. Clinical Trial Registration- clinicaltrials.gov Indentifier: NCT00160134.

Topics & Keywords

Acute Kidney Injury Research Adenosine and Purinergic Signaling Renal and Vascular Pathologies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Circulation Heart Failure

Volume 2, Issue 6, pp. 523-531

DOI: 10.1161/circheartfailure.108.798389

Field-Weighted Citation Impact: 2.73